Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
11,920
-890 (-6.95%)
At close: Feb 27, 2026
240.57% (1Y)
| Market Cap | 329.92B |
| Revenue (ttm) | 108.14B |
| Net Income (ttm) | 1.41B |
| Shares Out | 27.68M |
| EPS (ttm) | 60.34 |
| PE Ratio | 197.55 |
| Forward PE | n/a |
| Dividend | 30.00 (0.25%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 3,312,278 |
| Average Volume | 4,513,577 |
| Open | 12,800 |
| Previous Close | 12,810 |
| Day's Range | 11,710 - 12,800 |
| 52-Week Range | 2,995 - 15,960 |
| Beta | 0.82 |
| RSI | 48.99 |
| Earnings Date | n/a |